Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Syntis Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Syntis Bio

Syntis Bio

Series B

Syntis Bio develops novel oral therapies with targeted drug delivery technology to enhance bioavailability.

HQ
Milton, MA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Syntis Bio, founded with the mission to revolutionize drug delivery, focuses on developing novel oral therapies that utilize advanced targeted delivery technology to enhance bioavailability. The company's core vision is to improve patient outcomes by creating more effective and efficient drug formulations. Their primary market focus is on late-stage preclinical development, aiming to address unmet medical needs through innovative therapeutic solutions.

Notable figures associated with Syntis Bio include experienced scientists and industry veterans who bring a wealth of knowledge in pharmaceutical development. The company has garnered attention from prominent investors in the biotech sector, underscoring its potential impact. Key achievements include significant advancements in their drug delivery technology, positioning Syntis Bio as a promising player in the field of targeted oral therapies. Their work has the potential to transform treatment paradigms and improve the efficacy of various medications.

Syntis Bio - Similar Companies

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Synereca Pharmaceuticals logo

Synereca Pharmaceuticals

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Cytonus Therapeutics logo

Cytonus Therapeutics

cytonus.com

Synspira logo

Synspira

Transpire Bio logo

Transpire Bio

transpirebio.com

Lindy Biosciences logo

Lindy Biosciences

lindybio.com

Receptor Life Sciences logo

Receptor Life Sciences

receptorlife.com

SpringLeaf Therapeutics logo

SpringLeaf Therapeutics

Intact Therapeutics logo

Intact Therapeutics

Synthex logo

Synthex

bioSyntagma logo

bioSyntagma

biosyntagma.com

Surf Bio logo

Surf Bio

surf.bio

Syntis Bio - Quick Facts

Who are Syntis Bio's competitors?

Companies similar to Syntis Bio include i2o Therapeutics, Synereca Pharmaceuticals, Forward Therapeutics and Synnovation Therapeutics.

When was Syntis Bio founded?

Syntis Bio was founded in 2022.

Where is Syntis Bio's headquarters located?

Syntis Bio's headquarters is located in Milton, MA, US.

When was Syntis Bio's last funding round?

Syntis Bio's most recent funding round was for $15.4M (USD) in January 2023.

How much has Syntis Bio raised to-date?

As of Jan 17, 2023, Syntis Bio has raised a total of $15.4M (USD).

How many employees does Syntis Bio have?

Syntis Bio has 7 employees as of Feb 5, 2024.

Syntis Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified